LABORATORY CORP OF AMERICA HOLDINGS Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 251.58 | 3,595 | 904,430 | 37,433 | 41 K to 37.4 K (-8.76 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Grant | A | 0.00 | 8,042 | 0 | 41,028 | 33 K to 41 K (+24.38 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 251.58 | 1,079 | 271,455 | 14,186 | 15.3 K to 14.2 K (-7.07 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Grant | A | 0.00 | 2,413 | 0 | 15,265 | 12.9 K to 15.3 K (+18.78 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Caveney Brian J | EVP, President of D ... | Payment of Exercise | F | 251.58 | 1,079 | 271,455 | 8,001 | 9.1 K to 8 K (-11.88 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Caveney Brian J | EVP, President of D ... | Grant | A | 0.00 | 2,413 | 0 | 9,080 | 6.7 K to 9.1 K (+36.19 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Payment of Exercise | F | 251.58 | 790 | 198,748 | 9,786 | 10.6 K to 9.8 K (-7.47 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Grant | A | 0.00 | 2,104 | 0 | 10,576 | 8.5 K to 10.6 K (+24.83 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 251.58 | 1,079 | 271,455 | 5,673 | 6.8 K to 5.7 K (-15.98 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Grant | A | 0.00 | 2,413 | 0 | 6,752 | 4.3 K to 6.8 K (+55.61 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Payment of Exercise | F | 251.58 | 687 | 172,835 | 6,049 | 6.7 K to 6 K (-10.20 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Grant | A | 0.00 | 2,310 | 0 | 6,736 | 4.4 K to 6.7 K (+52.19 %) |
| Mar 29 2021 | LH | LABORATORY CORP OF ... | Wengel Kathryn E | Director | Option Exercise | A | 0.00 | 603 | 0 | 603 |